Cation-pi Interactions Contribute Significantly To The Stability Of The D2 Domain Of Fibroblast Growth Factor Receptor

被引：0
|
作者：
Thurman, Ryan [1 ]
Rajalingam, Dakshinamurthy [1 ]
Kumar, T. K. S. [1 ]
机构：
[1] Univ Arkansas, Fayetteville, AR 72701 USA
来源：
BIOPHYSICAL JOURNAL | 2009年 / 96卷 / 03期
关键词：
D O I：
10.1016/j.bpj.2008.12.1673
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1701-Pos
引用
收藏
页码：332A / 332A
页数：1
相关论文
共 50 条
  • [41] Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation
    Snider, Ashley J.
    Zhang, Zhihong
    Xie, Yuhuan
    Meier, Kathryn E.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 298 (01): : C163 - C170
  • [42] Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain
    Burgar, HR
    Burns, HD
    Elsden, JL
    Lalioti, MD
    Heath, JK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) : 4018 - 4023
  • [43] SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor β-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (269):
  • [44] Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells
    Zhang, Liyong
    Zhao, Zhenlong
    Xu, Shuping
    Tandon, Manuj
    LaValle, Courtney R.
    Deng, Fan
    Wang, Q. Jane
    ONCOTARGET, 2017, 8 (08) : 12800 - 12811
  • [45] Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
    Li, Jie
    Zhu, Shan
    Kozono, David
    Ng, Kimberly
    Futalan, Diahnn
    Shen, Ying
    Akers, Johnny C.
    Steed, Tyler
    Kushwaha, Deepa
    Schlabach, Michael
    Carter, Bob S.
    Kwon, Chang-Hyuk
    Furnari, Frank
    Cavenee, Webster
    Elledge, Stephen
    Chen, Clark C.
    ONCOTARGET, 2014, 5 (04) : 882 - 893
  • [46] Fibroblast growth factor receptor 2 (FGFR2) interacts with FGF23 and type IIa Na-Pi cotransporter (NaPi cotrartsporter) in OK cells.
    Yokote, H
    Yan, X
    Yao, L
    Liang, S
    Fujita, K
    Jing, X
    Okuno, E
    Sakaguchi, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S189 - S189
  • [47] MULTIPLE STRUCTURAL ELEMENTS DETERMINE LIGAND-BINDING OF FIBROBLAST GROWTH-FACTOR RECEPTORS - EVIDENCE THAT BOTH IG DOMAIN-2 AND DOMAIN-3 DEFINE RECEPTOR SPECIFICITY
    ZIMMER, Y
    GIVOL, D
    YAYON, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (11) : 7899 - 7903
  • [48] GENOME-WIDE shRNA SCREEN REVEALED SYNTHETIC LETHAL INTERACTION BETWEEN DOPAMINE RECEPTOR D2 (DRD2) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITION IN GLIOBLASTOMA
    Zhu, Shan
    Kozono, David
    Li, Jie
    Kushwaha, Deepa
    Carter, Bob
    Chen, Clark
    NEURO-ONCOLOGY, 2013, 15 : 14 - 14
  • [49] Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-β in human bronchial epithelial cells
    Wang, LX
    Cummings, R
    Zhao, YT
    Kazlauskas, A
    Sham, JKS
    Morris, A
    Georas, S
    Brindley, DN
    Natarajan, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) : 39931 - 39940
  • [50] Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3
    Achen, MG
    Roufail, S
    Domagala, T
    Catimel, B
    Nice, EC
    Geleick, DM
    Murphy, R
    Scott, AM
    Caesar, C
    Makinen, T
    Alitalo, K
    Stacker, SA
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09): : 2505 - 2515
12345